The global genomics market reached strong growth in 2020. Going forward, the market is expected to grow at a CAGR of around 16% during 2021-2026, according to the latest report from IMARC Group.
Genomics refers to the study of the function, structure, and inheritance of an organism’s genome. It addresses the intra-relationship of all genes to identify their combined influence on overall development. It involves multiple systems, consumables, software and services for diagnostics, drug discovery, and the development of precision medicine. Some of the technologies used for genomics include nucleic acid extraction, polymerase chain reaction (PCR), and single-cell genomic analysis.
Note: We regularly monitor the direct effect of COVID-19[female[feminine on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Request a free sample report:
One of the key factors enhancing the growth of the market is the increasing prevalence of chronic diseases. In addition, genomic data is widely used to produce targeted and personalized drugs and study the growth of military genomics in clinical workflows. This, together with an increasing use of genetically modified (GM) plants and organisms in the agricultural sector, is propelling the growth of the market. In addition, technological advancements such as the introduction of genomics-based tests and applications and extensive research and development (R&D) in the field of bioinformatics are also supporting the growth of the market.
Ask the analyst and go through the full report with the table of contents and list of figures: https://bit.ly/2LnYx4T
Breakdown by component:
- Some products
- Instruments and software
- Consumables and reagents
- Basic genomics services
- NGS-based services
- Biomarker translation services
- IT services
Breakdown by application:
- Functional genomics
- Discovery of biomarkers
- Track analysis
Breakdown by technology:
- Polymerase chain reaction
- Nucleic acid extraction and purification
Breakdown by end user:
- Research centers
- Hospitals and clinics
- Pharmaceutical and biotechnology companies
Distribution by geography:
- North America (United States and Canada)
- Europe (Germany, UK, France, Italy, Spain, Russia and others)
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Australia and others)
- Latin America (Brazil, Mexico)
- Middle East and Africa
The report also analyzed the competitive landscape of the market with some of the major players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.
Highlights of the report:
- Market performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market drivers and success factors
- SWOT analysis
- Value chain
- Complete mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.
The IMARC group is a leading market research company providing management strategies and market research worldwide. We partner with clients across industries and regions to identify their most exciting opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include key business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasting and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and new processing methods are at the top of the market. business expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: + 1-631-791-1145 | Europe & Africa: + 44-753-713-2163 | Asia: + 91-120-433-0800